Abstract:For both in situ or ex situ regeneration of tissues to be repaired,an ideal tissue engineering scaffold should create a local environment to facilitate homing,induced differentiation,and proliferation in addition to its molding function.For a tissue engineering scaffold to achieve this objective,releasing the relevant cell growth factors for sufficient period of time is more efficient and natural over that by material morphology.However,protein drugs are delicate and easily denatured by the harsh conditions of preparation for tissue engineering scaffolds,which may evoke undesirable antibody responses.None of the tissue engineering scaffolds reported to date have achieved long-term sustained-release of cell growth factor proteins in native conformation.To overcome this still-standing hurdle,the present study demonstrated a method to load cytokine proteins into tissue-engineering fibers with preserved native conformation for achieving long term sustained-release.We first preloaded vascular endothelial growth factor (VEGF165) as the model protein into dextran nanoparticles without contacting water-oil or water-gas interface (recognized protein conformation killer) by utilizingthe freezing induced aqueous phase separation method developed in our lab.Then the VEGF165 protected in the matrix of dextran particles were suspended in a solution of poly (lactic-co-glycolic acid) (PLGA) prior to electrospinning to form fibers.In order to avoid burst release in the initial stage by the protein-preloaded particles exposed at the fiber surface,another layer of PLGA fiber which carried no VEGF165 was spanned on the top of the already formed PLGA fiber membrane.A series of physicochemical characterizations comprising scanning electron microscopy (SEM),contact angle,mechanical strength,confirmed that the tissue engineering fibers formed above possessed satisfied surface texture and mechanical strength.The VEGF165 was recovered after each of the preparation step and assayed using CCK-8 test for bioactivity.The results indicated that the VEGF165 recovered from the dextran nanoparticles retained＞97 ％ bioactivity,and that from the final fiber was above 87 ％,both were remarkably higher than that recovered from the fibers formed in which the protein was preloaded in solution form (＜55 ％).In vitro release test showed that nanoparticles composite fibers prepared as above achieved a sustained-release profile with minimal initial burst and un-released residue.The protein was released less than 35 ％ of the total load in the initial five days and over 92％ at day 25.For the fibers wherein VEGF16s was loaded in the solution form,the 53.12 ％ of protein load was released in the initial five days,and 84.52 ％ was released at day 25.The therapeutic efficacy of the VEGF165 loaded fiber membranes were examined on the rat model of lowerlimb ischemia,followed immunohistochemistry observation.The results indicated that the regenerated blood vessels by dextran nanoparticles composite PLGA fibers were significantly more than that by the fibers to which VEGF165 was loaded in solution form.As conclusion,pre-loading proteins in polysaccharide nanoparticles prior to electrospinning was an effective method to prepare efficacious tissue engineere fibers for sustained-release cell growth factored with preserved bioactivity and improved release kinetics.

Preparation of Fiber-Microsphere Scaffolds for Loading Bioactive Substances in Gradient Amounts

Fibre–Microsphere Membranes with Continuous BMP-2 Gradients with Potential Applications in Interface-tissue Engineering

Dual gradients of bioactive components on electrospun fibers for cell migration and controlled stem cell differentiation

Electrospun Fibrous Scaffolds with Continuous Gradations in Mineral Contents and Biological Cues for Manipulating Cellular Behaviors.

Preparation and Cytocompatibility of Plga Scaffolds with Controllable Fiber Morphology and Diameter Using Electrospinning Method

Preparation of PLGA Scaffolds with Graded Pores by Using a Gelatin-Microsphere Template as Porogen.

Fabrication and Characterization of Dual Drug-Loaded Poly (Lactic-Co-glycolic Acid) Fiber-Microsphere Composite Scaffolds

Co-electrospun Nano-/Microfibrous Composite Scaffolds with Structural and Chemical Gradients for Bone Tissue Engineering.

Preparation and Protein Sustained-release System of Electrospinning Nanofibers

Bicomponent Fibrous Scaffolds Of Controlled Composition For Tissue Engineering Applications

Preparation and biocompatibility of electrospun poly(l-lactide-co-ε- caprolactone)/fibrinogen blended nanofibrous scaffolds

Electrospinning of PLGA/gelatin Randomly-Oriented and Aligned Nanofibers As Potential Scaffold in Tissue Engineering

Fabrication of Multilayered Electrospun Poly(lactic-Co-glycolic Acid)/polyvinyl Pyrrolidone Plus Poly(ethylene Oxide) Scaffolds and Biocompatibility Evaluation

Electrospun PLGA/SF Modified with Electrosprayed Microparticles: A Novel Biomimetic Composite Scaffold for Vascular Tissue Engineering

Bioactive Electrospun Scaffolds Delivering Growth Factors and Genes for Tissue Engineering Applications

Macroporous and nanofibrous poly(lactide-co-glycolide)(50/50) scaffolds via phase separation combined with particle-leaching

Emulsion Electrospinning of Nanofibrous Delivery Vehicles for the Controlled Release of Biomolecules and the in Vitro Release Behaviour of Biomolecules

Diverse Release Behaviors of Water-Soluble Bioactive Substances from Fibrous Membranes Prepared by Emulsion and Suspension Electrospinning.

Novel Electrospun Bicomponent Scaffolds for Bone Tissue Engineering: Fabrication, Characterization and Sustained Release of Growth Factor

A hybrid electrospinning and electrospraying 3D printing for tissue engineered scaffolds

Novel preparation of controlled porosity particle/fibre loaded scaffolds using a hybrid micro-fluidic and electrohydrodynamic technique